SCHEMBL4657331

SCHEMBL4657331

CCCc1ccc(C(=O)N(C)c2ccc(C(=O)NO)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 10/20 0.56
HDAC6 Q9UBN7 9/20 0.56
PLK1 P53350 1/20 0.54
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
POLB P06746 2/20 0.52
CTDSP1 Q9GZU7 2/20 0.52
HDAC3 O15379 2/20 0.51
HDAC2 Q92769 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
HDAC8 Q9BY41 3/20 0.50
NR1H4 Q96RI1 1/20 0.49
ALDH1A1 P00352 2/20 0.49
GAA P10253 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TRPV1 Q8NER1 1/20 0.47
LMNA P02545 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC10 Q969S8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4656484 1.00 HDAC1 (0.56) HDAC1HDAC6PLK1ESR1ESR2
SCHEMBL4657440 0.92 HDAC1 (0.59) HDAC1HDAC6PLK1HDAC3HDAC2
SCHEMBL4658151 0.92 HDAC1 (0.59) HDAC1HDAC6PLK1HDAC3HDAC2
SCHEMBL4657457 0.88 HDAC6 (0.59) HDAC1HDAC6PLK1HDAC3HDAC2
SCHEMBL4654830 0.88 HDAC6 (0.59) HDAC1HDAC6PLK1HDAC3HDAC2
SCHEMBL6918978 0.84 PLK1 (0.72) HDAC1HDAC6PLK1POLBCTDSP1
SCHEMBL13181080 0.82 ESR1 (0.55) ESR1ESR2NR1H4ALDH1A1KDM4E
SCHEMBL15480654 0.82 HDAC6 (0.72) HDAC1HDAC6POLBHDAC3HDAC2
SCHEMBL4659080 0.80 HDAC6 (0.67) HDAC1HDAC6HDAC3HDAC2HDAC8
SCHEMBL4610487 0.80 HDAC1 (0.61) HDAC1HDAC6HDAC3HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660437-B1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORP (KR) 2008-10-15 EP claimed
US-7282522-B2 Hydroxamic acid derivatives and the method for preparing thereof AMOREPACIFIC CORPORATION (KR) 2007-10-16 US claimed
US-20060252834-A1 Hydroxamic acid derivatives and the method for preparing thereof AMOREPACIFIC CORPORATION (KR) 2006-11-09 US claimed
EP-1660437-A4 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORP (KR) 2006-09-20 EP claimed
EP-1660437-A1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF Amorepacific Corporation (KR) 2006-05-31 EP claimed
WO-2005019162-A1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORPORATION (KR) 2005-03-03 WO claimed
EP-1660437-B1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORP (KR) 2008-10-15 EP disclosed
US-7282522-B2 Hydroxamic acid derivatives and the method for preparing thereof AMOREPACIFIC CORPORATION (KR) 2007-10-16 US disclosed
US-20060252834-A1 Hydroxamic acid derivatives and the method for preparing thereof AMOREPACIFIC CORPORATION (KR) 2006-11-09 US disclosed
EP-1660437-A4 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORP (KR) 2006-09-20 EP disclosed
EP-1660437-A1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF Amorepacific Corporation (KR) 2006-05-31 EP disclosed
WO-2005019162-A1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORPORATION (KR) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252834-A1 Hydroxamic acid derivatives and the method for preparing thereof HDAC7, SIRT7, HCAR1 HDAC1 67/4885HDAC6 201/4885PLK1 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.